Calendar Matinas BioPharma Holdings, Inc.

Equities

MTNB

US5768101058

Market Closed - Nyse 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
0.271 USD -6.52% Intraday chart for Matinas BioPharma Holdings, Inc. +1.80% +25.35%

Chart calendar Matinas BioPharma Holdings, Inc.

88881353eb657e86977.crizYTBTNRpt0SH1zpUSqD_57Ti-nrsSwwollBv55oI.O-L0FnYxY34CsEedp_5czHqt3wzr-otXs2FO-HC1i_Eb4ORRHR5eSguwUg~366468f73b49e0ec2b3c378703c7a309

Upcoming events on Matinas BioPharma Holdings, Inc.

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-17 Q4 2024 Earnings Release (Projected)

Past events on Matinas BioPharma Holdings, Inc.

2024-03-27 04:30 pm Q4 2023 Earnings Call
2024-03-27 04:05 pm Q4 2023 Earnings Release
2024-01-09 02:00 pm Biotech Showcase
2023-11-08 04:30 pm Q3 2023 Earnings Call
2023-11-08 04:05 pm Q3 2023 Earnings Release
2023-11-01 09:00 am Annual General Meeting
2023-10-19 11:00 am ThinkEquity Conference
2023-10-12 03:30 pm Dawson James Small Cap Growth Conference
2023-10-12 08:12 am IDWeek Conference
2023-09-10 H.C. Wainwright Global Investment Conference
2023-08-09 04:30 pm Q2 2023 Earnings Call
2023-08-09 04:05 pm Q2 2023 Earnings Release
2023-08-06 BTIG Virtual Biotechnology Conference
2023-05-15 09:30 am JMP Securities Life Sciences Conference
2023-05-10 04:30 pm Q1 2023 Earnings Call
2023-05-10 04:05 pm Q1 2023 Earnings Release
2023-04-17 Clinical Microbiology & Infectious Diseases European Congress - Marisa H
2023-04-17 Clinical Microbiology & Infectious Diseases European Congress - David Boulware
2023-03-15 04:30 pm Q4 2022 Earnings Call
2023-03-15 04:05 pm Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,09
0,11
-21.42%
0,16
1,12
-85.82%
0,03
0,36
-90.8%
3,19
2,87
11.04%
1,10
1,10
-0.18%

0,00

EBITDA
Million USD
Released
Forecast
Spread
-18,7
-17,6
-6.34%
-24,0
-24,4
1.74%
-24,5
-24,9
1.65%
-24,3
-24,1
-0.63%
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-18,9
-18,3
-3.47%
-24,2
-23,4
-3.37%
-24,7
-25,6
3.27%
-24,6
-25,8
4.8%
-23,8
-24,1
1.33%

-26,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-17,4
-17,3
-0.35%
-22,4
-21,4
-4.94%
-23,3
-24,2
3.89%
-21,0
-24,1
12.71%
-22,9
-23,8
3.7%

-28,1

Net income
Million USD
Released
Forecast
Spread
-18,3
-17,7
-3.34%
-23,2
-22,0
-5.84%
-23,7
-24,5
3.31%
-21,0
-24,1
12.71%
-22,9
-23,7
3.25%

-26,6

EPS
USD
Released
Forecast
Spread
-0,13
-0,12
-5.41%
-0,12
-0,12
-4.35%
-0,11
-0,12
8.33%
-0,10
-0,11
9.09%
-0,11
-0,11
0%

-0,12

Announcement Date09/03/2029/03/2108/03/2215/03/2327/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,45
-
0,00
0,00
-
1,06
0,06
1546.01%
1,06
0,85
25.52%
1,06
0,72
47.43%
1,10
0,30
265.33%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread
-6,65
-7,10
6.35%
-7,65
-6,30
-21.48%
-5,84
-6,40
8.76%
-5,37
-5,80
7.36%
-5,39
-5,30
-1.64%
-5,49
-5,80
5.29%





















EBIT
Million USD
Released
Forecast
Spread
-6,71
-7,56
11.13%
-7,72
-6,71
-15.05%
-5,93
-7,24
18.11%
-5,46
-6,31
13.4%
-5,48
-5,89
7.01%
-5,59
-5,90
5.32%
-6,16
-6,72
8.41%
-6,13
-6,21
1.23%
-5,89
-6,20
5.01%

-6,30


-6,30


-6,40


-6,40

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,70
-7,64
12.33%
-5,98
-6,99
14.53%
-5,92
-7,23
18.07%
-5,46
-6,30
13.37%
-3,63
-5,89
38.28%
-5,51
-5,90
6.56%
-6,06
-6,75
10.21%
-6,06
-6,22
2.67%
-5,31
-6,20
14.22%












Net income
Million USD
Released
Forecast
Spread
-6,70
-7,64
12.33%
-5,98
-6,99
14.53%
-5,92
-7,23
18.07%
-5,46
-6,30
13.37%
-3,63
-5,89
38.28%
-5,51
-5,90
6.56%
-6,06
-6,72
9.88%
-6,06
-6,17
1.87%
-5,31
-6,10
12.85%

-6,10


-6,20


-6,40


-6,50

EPS
USD
Released
Forecast
Spread
-0,03
-0,04
20%
-0,03
-0,03
0%
-0,03
-0,03
7.69%
-0,03
-0,03
0%
-0,02
-0,03
25.01%
-0,03
-0,03
0%
-0,03
-0,03
0%
-0,03
-0,03
0%
-0,03
-0,03
0%

-0,03


-0,03


-0,03


-0,03

Announcement Date08/03/2212/05/2211/08/2202/11/2215/03/2310/05/2309/08/2308/11/2327/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Matinas BioPharma Holdings, Inc. - Nyse
  4. Calendar Matinas BioPharma Holdings, Inc.